Showing results (231-240 of 326) with videos related to

Sort By:
Pageof 33
Practical Radiation Oncology|August 20, 2016
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery With Whole-Breast Irradiation in Ductal Carcinoma in SituMonica Morrow, Kimberly J Van Zee, Lawrence J Solin, et al.
Annals of Surgical Oncology|July 29, 2025
Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor SubtypeEllery H Reason, Samantha M Thomas, Tori Chanenchuk, et al.
Breast Cancer Research : BCR|September 17, 2024
Impact of an online decision support tool for ductal carcinoma in situ (DCIS) using a pre-post design (AFT-25)Elissa M Ozanne, Kellyn Maves, Angela C Tramontano, et al.
Nature Medicine|March 18, 2014
Tissue mechanics modulate microRNA-dependent PTEN expression to regulate malignant progressionJanna K Mouw, Yoshihiro Yui, Laura Damiano, et al.
Clinical Breast Cancer|December 12, 2024
Climate Therapy: Sustainability Solutions for Breast Cancer Care in the Anthropocene EraSeamus O'Reilly, Emer Lynch, E Shelley Hwang, et al.
The Journal of Surgical Research|February 15, 2024
Anatomy Versus Biology: What Guides Chemotherapy Decisions in Older Patients With Breast Cancer?Sydney M Record, Samantha M Thomas, William M Tian, et al.
Cancer|February 14, 2026
Breast cancer staging for patients with "low-risk" disease: Are they all the same?Tori C Nierenberg, Samantha M Thomas, Ellery H Reason, et al.
Annals of Surgical Oncology|November 23, 2025
Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast CancerTon Wang, Drew Neish, Samantha Thomas, et al.
The American Journal of Surgical Pathology|August 25, 2009
Genetic and phenotypic characteristics of pleomorphic lobular carcinoma in situ of the breastYunn-Yi Chen, Eun-Sil Shelley Hwang, Ritu Roy, et al.
Cancer|February 26, 2013
Magnetic resonance imaging as a predictor of pathologic response in patients treated with neoadjuvant systemic treatment for operable breast cancer. Translational Breast Cancer Research Consortium trial 017Jennifer F De Los Santos, Alan Cantor, Keith D Amos, et al.
Pageof 33